FTO and INSIG2 genotyping combined with metabolic and anthropometric phenotyping of morbidly obese patients

Molecular Syndromology

Volumn 4, Issue 6, 2013, Pages 273-279

  Burgdorfer E ^a   Korenkov, M ^b   Jonas, D ^a   Weise, D ^a   Haaf, T ^c   Zechner, U ^a   Bartsch, O ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Department of Neurology   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Association; FTO; INSIG2; Metabolic and anthropometric phenotyping; Morbid obesity; SNPs

Indexed keywords

FTO PROTEIN; INSIG2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; ASPARTATE AMINOTRANSFERASE; HEMOGLOBIN A1C;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; FAT MASS AND OBESITY ASSOCIATED GENE; GENE; GENE IDENTIFICATION; GENETIC RISK; GERMANY; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; INSULIN INDUCED GENE 2; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; NONALCOHOLIC FATTY LIVER; WAIST HIP RATIO;

EID: 84883737892     PISSN: 16618769     EISSN: 16618777     Source Type: Journal    
DOI: 10.1159/000353563     Document Type: Article

References (15)

1. Chu X, Erdman R, Susek M, Gerst H, Derr K, et al: Association of morbid obesity with FTO and INSIG2 allelic variants. Arch Surg 143: 235-240 (2008
2. Church C, Lee S, Bagg EA, McTaggart JS, Deacon R, et al: A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genet 5:e1000599 (2009
3. Dina C, Meyre D, Gallina S, Durand E, Korner A, et al: Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39: 724-726 (2007
4. Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, et al: Inactivation of the Fto gene protects from obesity. Nature 458: 894-898 (2009
5. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316: 889-894 (2007
6. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, et al: The obesity-Associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318: 1469-1472 (2007
7. Hardy R, Wills AK, Wong A, Elks CE, Wareham NJ, et al: Life course variations in the associations between FTO and MC4R gene variants and body size. Hum Mol Genet 19: 545-552 (2010
8. Heid IM, Huth C, Loos RJ, Kronenberg F, Adamkova V, et al: Meta-Analysis of the INSIG2 association with obesity including 74,345 individuals: Does heterogeneity of estimates relate to study design? PLoS Genet 5:e1000694 (2009
9. Herbert A, Gerry NP, McQueen MB, Heid IM, Pfeufer A, et al: A common genetic variant is associated with adult and childhood obesity. Science 312: 279-283 (2006
10. Hinney A, Vogel CI, Hebebrand J: From monogenic to polygenic obesity: Recent advances. Eur Child Adolesc Psychiatry 19: 297-310 (2010
11. Lyon HN, Emilsson V, Hinney A, Heid IM, Lasky-Su J, et al: The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not in all cohorts. PLoS Genet 3:e61 (2007
12. Reinehr T, Hinney A, Nguyen TT, Hebebrand J: Evidence of an influence of a polymorphism near the INSIG2 on weight loss during a lifestyle intervention in obese children and adolescents. Diabetes 57: 623-626 (2008
13. Reinehr T, Hinney A, Toschke AM, Hebebrand J: Aggravating effect of INSIG2 and FTO on overweight reduction in a one-year lifestyle intervention. Arch Dis Child 94: 965-967 (2009
14. Walley AJ, Asher JE, Froguel P: The genetic contribution to non-syndromic human obesity. Nat Rev Genet 10: 431-442 (2009
15. World Health Organization: Chapter 1. The challenge, in Branca F, Nikogosian H, Lobstein T (eds): The Challenge of Obesity in the WHO European Region and the Strategies for Response: Summary, pp 1-12 (World Health Organisation, Copenhagen 2007